INTRODUCTION {#sec1-1}
============

The genus *Ligularia*, a member from the family compositae, comprises approximately 150 species worldwide and nearly 120 species are distributed in China.\[[@ref1]\] The roots and rhizomes of many *Ligularia* plants have long been used as folk medicines for their antibacterial and anti-inflammatory activities in China.\[[@ref2]\] The former phytochemical studies on this genus have revealed that it was an important source of terpenoids.\[[@ref3]\]

*Ligularia kangtingensis* S. W. Liu is an indigenous plant in Sichuan province, China, and it well adapted to highlands around 4000 m.\[[@ref4]\] A literature survey indicated that no phytochemical research was reported, except a study on volatile oil.\[[@ref5]\] As a continuation of our phytochemical studies on medicinal plants, herein we report the isolation of 12 known compounds, including two monoterpenoids, namely (3*R*, 4*R*, 6*S*)-3, 6-dihydroxy-1-menthene (11), 5-*p*-methane-1, 2-diol (12), five sesquiterpenoids, namely ligudentatin A (2), liguhodgsonal (3), oplopanone (4), 1β, 6α-dihydroxy-4β (15)-epoxyeudesmane (5), 8β-ethoxyeremophil-3, 7 (11)-diene-8α, 12 (6α, 15)-diolide (10) and 5 triterpenoids, namely lupeol (1), oleanolic acid (6), ursolic acid (7), pomolic acid (8), taraxerol (9) from the whole plant of *L. kangtingensis*.

MATERIALS AND METHODS {#sec1-2}
=====================

General {#sec2-1}
-------

Nuclear magnetic resonance (NMR) spectra were recorded on Varian Unity 400/54 spectrometer with tetramethylsilane as an internal standard. Column chromatography (CC) was carried out by using silica gel (Qingdao Marine Chemical Industry, 200--300 mesh) and Sephadex LH-20 (GE Healthcare). All the reagents and solvents used for separation and purification were analytical grade and purchased from local firms.

Plant material {#sec2-2}
--------------

The whole plant of *L. kangtingensis* was collected from Kangding County, Sichuan Province, China, in August, 2010. The plant was identified by Qin-Mao Fang, Institute of TCM Medicinal Resources and Cultivation, Sichuan Academy of Chinese Medicine Sciences. A voucher specimen (No. LK1008) was deposited in the School of Life Science and Technology, University of Electronic Science and Technology of China.

Extraction and isolation {#sec2-3}
------------------------

The air-dried whole plant of *L. kangtingensis* (5 kg) was powdered and extracted three times with 95% EtOH under reflux. The solvents were evaporated in vacuo to yield ethanol extract, which was suspended in H~2~O and then extracted with petroleum ether and EtOAc, respectively. The petroleum ether extract (185 g) was subjected to CC over silica gel (200--300 mesh, 2 kg) and eluted with a gradient solvent system (CHCl~3~-MeOH, 90:1--2:1) to give 12 fractions (Fr. 1\~12). Fr. 2 (1.4 g) was isolated by silica gel chromatography eluted with solvent systems of cyclohexane-EtOAc (18:1) and CHCl~3~-acetone (600:1) to afford compound 1 (50 mg). Fr. 5 (2.7 g) was separated by silica gel chromatography (petroleum ether-EtOAc, 10:1--6:1) to give eight subfractions (Fr. 5--1 \~ 5--8). Subfraction 5--2 (35 mg) was separated by preparative thin-layer chromatography (TLC) (CHCl~3~-acetone, 37:2) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to give compound 2 (5 mg); Subfraction 5--3 (30 mg) was separated by preparative TLC (CHCl~3~-acetone, 20:1) to give compound 3 (11 mg); Subfraction 5--4 (60 mg) was separated by silica gel chromatography (CHCl~3~-acetone, 70:1) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to give compound 4 (7 mg); Subfraction 5--6 (95 mg) was separated by silica gel chromatography (CHCl~3~-acetone, 55:1) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to give compound 5 (6 mg). Fr. 7 (750 mg) was isolated by silica gel chromatography (petroleum ether-EtOAc, 9:1; CHCl~3~-acetone, 50:1) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to afford compound 6 (11 mg). Fr. 9 (1 g) was isolated by silica gel chromatography eluted with solvent systems of CHCl~3~-acetone (60:1) and cyclohexane-EtOAc (6.5:1) to afford compound 7 (10 mg). Fr. 10 (3.5 g) was isolated by silica gel chromatography (petroleum ether-EtOAc, 6:1; CHCl~3~-acetone, 40:1) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to afford compound 8 (11 mg). The EtOAc extract (38 g) was subjected to CC over silica gel (200--300 mesh, 500 g) and eluted with a gradient solvent system (cyclohexane-acetone, 30:1--1:1) to give 10 fractions (Fr.A\~J). Fr. C (1.1 g) was isolated by silica gel chromatography (cyclohexane-EtOAc, 6:1) and recrystallized from cyclohexane to afford compound 9 (20 mg). Fr. D (180 mg) was isolated by silica gel chromatography (petroleum ether-EtOAc, 12:1) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to give compound 10 (6 mg). Fr. F (2.1 g) was isolated by silica gel chromatography (cyclohexane-EtOAc, 3:2; petroleum ether-acetone, 4:1) to afford subfraction F-1 and F-2. From subfraction F-1 (30 mg), compound 11 (7 mg) was recrystallized with CHCl~3~. Subfraction F-2 (240 mg) was isolated by silica gel chromatography (CHCl~3~-acetone, 35:1) and purified by Sephadex LH-20 chromatography (CHCl~3~-MeOH, 2:1) to afford compound 12 (6 mg).

RESULTS AND DISCUSSION {#sec1-3}
======================

Compound 1: White amorphous powder. ^1^H (400 MHz, CDCl~3~): *d*~H~ 4.68, 4.56 (each 1H, br s, H~2~-29), 3.17 (1H, m, H-3), 1.68, 1.03, 0.96, 0.94, 0.83, 0.79, 0.76 (each 3H, s, 7 × CH~3~). ^13^C NMR (100 MHz, CDCl~3~) \[[Table 1](#T1){ref-type="table"}\].

###### 

^13^C-NMR spectroscopic data for compound 1, 6, 7, 8 and 9

![](PM-11-44-g001)

Compound 2: Colorless gum. ^1^H (400 MHz, CDCl~3~): *d*~H~ 7.17 (1H, d, *J* = 2.8 Hz, H-3), 6.75 (1H, d, *J* = 2.8 Hz, H-1), 4.77 (2H, br s, H~2~-12), 3.86 (3H, s, OCH~3~), 3.17 (1H, dd, *J* = 17.6, 4.8 Hz, H-6α), 2.85 (2H, m, H~2~-9), 2.78 (1H, dd, *J* = 17.2, 11.2 Hz, H-6β), 2.26 (1H, m, H-7), 1.94 (1H, m, H-8α), 1.80 (3H, s, H~3~-13), 1.62 (1H, m, H-8β). ^13^C NMR (100 MHz, CDCl~3~): *d*~C~ 168.1 (C-14), 152.5 (C-2), 149.3 (C-11), 139.4 (C-10), 130.4 (C-4), 130.0 (C-5), 119.3 (C-1), 114.9 (C-3), 109.2 (C-12), 51.9 (OMe), 41.7 (C-7), 32.5 (C-6), 30.2 (C-9), 27.2 (C-8), 20.7 (C-13).

Compound 3: Colorless amorphous solid. ^1^H (400 MHz, CDCl~3~): *d*~H~ 10.25 (1H, s, H-14), 7.17 (1H, d, *J* = 2.8 Hz, H-3), 6.86 (1H, d, *J* = 2.4 Hz, H-12), 5.63 (1H, br s, OH), 4.79 (2H, br d, *J* = 9.2 Hz, H~2~-12),3.40 (1H, dd, *J* = 17.2, 4.8 Hz, H-6α), 1.81 (3H, s, H~3~-13). ^13^C NMR (100 MHz, CDCl~3~): d~C~ 192.6 (C-14), 153.5 (C-2), 149.0 (C-11), 139.8 (C-10), 134.6 (C-4), 131.7 (C-5), 121.7 (C-1), 115.6 (C-3), 109.6 (C-12), 41.4 (C-7), 30.7 (C-9), 29.9 (C-6), 27.0 (C-8), 20.7 (C-13).

Compound 4: Colorless gum. ^1^H (400 MHz, CDCl~3~): *d*~H~ 2.64 (1H, ddd, *J* = 14.2, 9.2, 5.2 Hz, H-3), 2.18 (3H, s, H~3~-15), 1.19 (3H, s, H~3~-14), 0.88 (3H, d, *J* = 6.8 Hz, H~3~-13), 0.68 (3H, d, *J* = 6.8 Hz, H~3~-12). ^13^C NMR (100 MHz, CDCl~3~): *d*~C~ 211.5 (C-4), 73.1 (C-10), 56.9 (C-1), 55.6 (C-5), 49.3 (C-7), 46.6 (C-6), 41.9 (C-9), 29.6 (C-15), 29.5 (C-11), 28.5 (C-3), 25.2 (C-2), 22.9 (C-8), 21.9 (C-13), 20.3 (C-14), 15.5 (C-12).

Compound 5: Colorless gum. ^1^H (400 MHz, CDCl~3~): *d*~H~ 3.43 (1H, t, *J* = 10.0 Hz, H-6), 3.42 (1H, dd, *J* = 12.4, 4.4 Hz, H-1), 3.21 (1H, dd, *J* = 3.6, 2.0 Hz, H-15a), 2.77 (1H, d, *J* = 3.6 Hz, H-15b), 1.65 (1H, d, *J* = 10.0 Hz, H-5), 0.91 (3H, d, *J* = 7.2 Hz, H~3~-12), 0.86 (3H, s, H~3~-14), 0.80 (3H, d, *J* = 6.8 Hz, H~3~-13). ^13^C NMR (100 MHz, CDCl~3~): *d*~C~ 78.0 (C-1), 67.5 (C-6), 61.5 (C-4), 51.5 (C-15), 49.6 (C-5), 49.6 (C-7), 41.8 (C-10), 36.7 (C-9), 33.1 (C-3), 29.2 (C-2), 24.9 (C-11), 20.9 (C-13), 17.8 (C-8), 15.8 (C-12), 12.1 (C-14).

Compound 6: White amorphous powder. ^1^H (400 MHz, CDCl~3~): *d*~H~ 5.27 (1H, br s, H-12), 3.21 (1H, m, H-3), 1.25, 1.13, 1.05, 0.98, 0.92, 0.90, 0.90 (each 3H, s, 7 × CH~3~). ^13^C NMR (100 MHz, CDCl~3~) \[[Table 1](#T1){ref-type="table"}\].

Compound 7: White amorphous powder. ^1^H (400 MHz, CD~3~OD): *d*~H~ 5.24 (1H, br s, H-12), 3.19 (1H, t, *J* = 8.0 Hz, H-3), 1.25, 1.26, 1.09, 0.98, 0.93 (each 3H, s, 5 × CH~3~), 0.95 (3H, d, *J* = 6.0 Hz, CH~3~), 0.86 (3H, d, *J* = 6.4 Hz, CH~3~). ^13^C NMR (100 MHz, CD~3~OD) \[[Table 1](#T1){ref-type="table"}\].

Coumpound 8: White amorphous powder. ^1^H (400 MHz, CDCl~3~): *d*~H~ 5.25 (1H, br s, H-12), 3.28 (1H, m, H-3), 1.17, 1.12, 0.89, 0.81, 0.68, 0.67 (each 3H, s, 6 × CH~3~), 0.85 (3H, d, *J* = 6.0 Hz, CH~3~). ^13^C NMR (100 MHz, CDCl~3~) \[[Table 1](#T1){ref-type="table"}\].

Compound 9: White needle crystal (cyclohexane). ^1^H (400 MHz, CDCl~3~): *d*~H~ 5.52 (1H, dd, *J* = 8.0, 2.8 Hz, H-15), 3.18 (1H, dd, *J* = 10.8, 4.4 Hz, H-3), 1.08, 0.97, 0.94, 0.92, 0.90, 0.81, 0.79 (each 3H, s, 7 × CH~3~). ^13^C NMR (100 MHz, CDCl~3~) \[[Table 1](#T1){ref-type="table"}\].

Compound 10: Colorless gum. ^1^H (400 MHz, CDCl~3~): *d*~H~ 6.85 (1H, t, *J* = 3.0 Hz, H-3), 5.04 (1H, dd, *J* = 2.8, 1.6 Hz, H-6), 3.53, 3.32 (each 1H, dq, *J* = 6.0, 4.8 Hz, H~2~-1′), 2.24 (1H, dd, *J* = 8.8, 3.2 Hz, H-9a), 2.00 (3H, d, *J* = 1.2 Hz, H~3~-13), 1.41 (3H, s, H~3~-14), 1.21 (3H, t, *J* = 4.8 Hz, H~3~-2′). ^13^C NMR (100 MHz, CDCl~3~): *d*~C~ 170.5 (C-12), 168.5 (C-15), 152.7 (C-7), 136.9 (C-3), 129.7 (C-4), 128.3 (C-11), 105.1 (C-8), 82.2 (C-6), 59.2 (C-1′), 44.0 (C-5), 35.6 (C-9), 33.0 (C-10), 26.9 (C-14), 21.7 (C-2), 21.5 (C-1), 15.1 (C-2′), 9.1 (C-13).

Compound 11: Colorless needle crystal (CHCl~3~). ^1^H (400 MHz, CD~3~OD): *d*~H~ 5.46 (1H, s, H-2), 3.90 (1H, br s, H-3), 3.84 (1H, d, *J* = 9.2 Hz, H-6), 2.10 (1H, m, H-8), 1.76 (3H, s, H~3~-7), 1.71 (1H, m, H-4),1.58 (1H, m, H-5a), 1.38 (1H, dt, *J* = 13.2, 4.0 Hz, H-5b), 0.96 (3H, d, *J* = 7.2 Hz, H~3~-10), 0.81 (3H, d, *J* = 6.8 Hz, H~3~-9). ^13^C NMR (100 MHz, CDCl~3~) *d*~C~ 136.9 (C-1), 129.6 (C-2), 69.3 (C-3), 67.9 (C-6), 42.4 (C-4), 29.9 (C-5), 26.3 (C-8), 20.9 (C-9), 20.3 (C-10), 17.1 (C-7).

Compound 12: Colorless gum. ^1^H (400 MHz, CDCl~3~): *d*~H~ 5.71 (1H, dd, *J* = 10, 2.8 Hz, H-5), 5.61 (1H, dd, *J* = 10.4, 1.2 Hz, H-6), 3.79 (1H, dd, *J* = 7.6, 3.2 Hz, H-2), 2.14 (1H, m, H-4), 1.80 (1H, m, H-8), 1.71 (2H, m, H~2~-3), 1.30 (3H, s, H~3~-7), 0.93 (3H, d, *J* = 6.4 Hz, H~3~-10), 0.92 (3H, d, *J* = 6.8 Hz, H~3~-9). ^13^C NMR (100 MHz, CDCl~3~): *d*~C~ 133.1 (C-5), 132.5 (C-6), 74.0 (C-2), 71.2 (C-1), 39.5 (C-4), 33.1 (C-8), 30.1 (C-3), 24.5 (C-7), 20.4 (C-10), 20.2 (C-9).

Identification of the 12 compounds isolated \[[Figure 1](#F1){ref-type="fig"}\] was based on comparison of ^1^H-NMR and ^13^C-NMR data with those reported in literature, and their structures were elucidated as lupeol (1),\[[@ref6]\] ligudentatin A (2),\[[@ref7]\] liguhodgsonal (3),\[[@ref8]\] oplopanone (4),\[[@ref9]\] 1β, 6α-dihydroxy-4β (15)-epoxyeudesmane (5),\[[@ref10]\] oleanolic acid (6),\[[@ref11]\] ursolic acid (7),\[[@ref11]\] pomolic acid (8),\[[@ref11]\] taraxerol (9),\[[@ref12]\] 8β-ethoxyeremophil-3, 7 (11)-diene-8α, 12 (6α, 15)-diolide (10),\[[@ref13]\] (3*R*, 4*R*, 6*S*)-3, 6-dihydroxy-1-menthene (11),\[[@ref14]\] 5-*p*-methene-1, 2-diol (12).\[[@ref15]\]

![Structure of compounds 1--12 isolated from *Ligularia kangtingensis*](PM-11-44-g002){#F1}

CONCLUSIONS {#sec1-4}
===========

Terpenoids, especially sesquiterpenoids, are the important secondary metabolites from plants for their diverse bioactivities, and this type of compounds is the major chemical constituent in the genus *Ligularia*. Here, our phytochemical investigation on the whole plant of *L. kangtingensis* has led to the isolation of 12 known terpenoids, including two monoterpenoids, five sesquiterpenoids and five triterpenoids, from this plant for the first time.
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